|
Sep 4
|
UPDATE 4-Wegovy makes UK weight-loss debut even as Novo struggles with supplies
|
|
Sep 4
|
UPDATE 1-Wegovy weight-loss drug will cost 199-299 pounds for private UK patients -Simple Online Pharmacy
|
|
Aug 29
|
Eli Lilly and Other Pharma Stocks Are Ignoring Medicare’s 10 Drug List
|
|
Aug 29
|
Shares of Wegovy Partner Catalent Jump After Striking Deal With Activist Investor Elliott
|
|
Aug 29
|
Biden admin unveils ten drugs picked for Medicare price negotiations
|
|
Aug 29
|
Does the Red-Hot Weight-Loss Market Make This Pharmaceutical Stock a Buy?
|
|
Aug 29
|
Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations
|
|
Aug 29
|
Why Wegovy's Sales Potential Could Be Massively Understated
|
|
Aug 28
|
3 Top Growth Stocks I'd Buy Right Now Without Hesitation
|
|
Aug 28
|
Is It Time to Take Some Gains in Novo Nordisk Stock? Not So Fast.
|
|
Aug 27
|
Who Would Bet Against Eli Lilly? I Would and Here's How
|
|
Aug 25
|
How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment
|
|
Aug 25
|
Novo Nordisk’s Wegovy Helped Heart-Failure Patients. What’s Next?
|
|
Aug 25
|
Novo Nordisk (NVO) Posts Upbeat Data From Heart Failure Study
|
|
Aug 25
|
Novo Nordisk's (NVO) Shares Jump 17% in a Month: Here's Why
|
|
Aug 25
|
Semaglutide 2.4 mg shows large reductions in heart failure-related symptoms and physical limitations in people with heart failure with preserved ejection fraction and obesity
|
|
Aug 24
|
Eli Lilly Has A Big Stake In Weight Loss And Alzheimer's Drugs; But Is The Stock A Buy?
|
|
Aug 24
|
CVS Health launches new brand Cordavis to target $100 billion biosimilar market
|
|
Aug 24
|
This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks Soaring
|
|
Aug 24
|
Elon Musk once used a weight loss drug to look 'fit, ripped and healthy' — now the company behind it is more valuable than the entire economy of Denmark. Here's what happened
|